Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.
How did DRTS's recent EPS compare to expectations?
The most recent EPS for Alpha Tau Medical Ltd is $-0.26, beating expectations of $-0.12.
How did Alpha Tau Medical Ltd DRTS's revenue perform in the last quarter?
Alpha Tau Medical Ltd revenue for the last quarter is $-0.26
What is the revenue estimate for Alpha Tau Medical Ltd?
According to 5 of Wall street analyst, the revenue estimate of Alpha Tau Medical Ltd range from $420.0K to $0.0
What's the earning quality score for Alpha Tau Medical Ltd?
Alpha Tau Medical Ltd has a earning quality score of B/42.840984. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Alpha Tau Medical Ltd report earnings?
Alpha Tau Medical Ltd next earnings report is expected in 2026-08-16
What are Alpha Tau Medical Ltd's expected earnings?
Alpha Tau Medical Ltd expected earnings is $64.59K, according to wall-street analysts.
Did Alpha Tau Medical Ltd beat earnings expectations?
Alpha Tau Medical Ltd recent earnings of $0.0 does not beat expectations.